ArticlePerspectives on sexual and reproductive health2025
"I Don't Really Agree With That:" Canadians' Perspectives on the 14-Day Rule in Relation to Artificial Womb Technology.
Article in Perspectives on sexual and reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionComplete ectogenesis through artificial womb technology (AWT) would enable fertilization, embryonic development, and fetal development outside of the human body. In 2004, Canada's Assisted Human Reproduction Act established a 14-day legal limit on the in vitro cultivation of human embryos, stymying the domestic development of AWT. Given recent scientific advancements, we aimed to explore Canadians' perspectives on the 14-day rule and AWT development.
methodsIn September 2020-February 2021, we conducted an online English-French survey and semi-structured in-depth interviews with a subset of respondents to solicit Canadian citizens' perspectives on AWT. We audio-recorded and transcribed the telephone/Zoom/Skype interviews and used ATLAS.ti to manage our data. We analyzed survey data using descriptive statistics and interviews for content and themes using inductive and deductive techniques.
resultsWe received 343 completed surveys and conducted 41 interviews. Although overall knowledge of AWT, in general, and the 14-day rule, in particular, was limited, our participants felt that AWT had the potential to improve lives. Participants also perceived the 14-day rule as an outdated limitation on technological progress and a barrier to AWT development. Participants suggested revisiting the legislation and emphasized centering science, technology, and medicine in any update. DISCUSSION: In 2021, the International Society for Stem Cell Research released updated guidelines which recommended relaxing the 14-day rule, depending on the research objectives. Given the changing domestic and international landscape, Canadian policymakers should revisit the 14-day rule limit imposed by the Assisted Human Reproduction Act and seek input from Canadians when embarking on this reform process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.